1. New Chalcones and Thiopyrimidine Analogues Derived from Mefenamic acid: Microwave-assisted Synthesis, anti-HIV Activity and Cytotoxicity as Antileukemic Agents. Al-Hazam, H.A., Z.A. Al-Shamkani, N.A. Al-Masoudi, B.A. Saeed, and C. Pannecouque. Zeitschrift fur Naturforschung Section B-A Journal of Chemical Sciences, 2017. 72(4): p. 249-256. ISI[000402130300003].
[WOS]. HIV_06_2017.
2. One Drug for Two Targets: Biological Evaluation of Antiretroviral Agents Endowed with Antiproliferative Activity. Botta, L., G. Maccari, P. Calandro, M. Tiberi, A. Brai, C. Zamperini, F. Canducci, M. Chiariello, R. Marti-Centelles, E. Falomir, and M. Carda. Bioorganic & Medicinal Chemistry Letters, 2017. 27(11): p. 2502-2505. PMID[28408224].
[PubMed]. HIV_06_2017.
3. Synthesis and Study of anti-HIV-1 RT Activity of 5-Benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one Derivatives. Chander, S., C.R. Tang, H.M. Al-Maqtari, J. Jamalis, A. Penta, T.B. Hadda, H.M. Sirat, Y.T. Zheng, and M. Sankaranarayanan. Bioorganic Chemistry, 2017. 72: p. 74-79. PMID[28371664].
[PubMed]. HIV_06_2017.
4. Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45. Falkenhagen, A. and S. Joshi. Molecular Therapy - Nucleic Acids, 2017. 7: p. 387-395. PMID[28624214].
[PubMed]. HIV_06_2017.
5. In Vitro Cross-resistance Profiles of Rilpivirine, Dapivirine, and MIV-150, Nonnucleoside Reverse Transcriptase Inhibitor Microbicides in Clinical Development for the Prevention of HIV-1 Infection. Giacobbi, N.S. and N. Sluis-Cremer. Antimicrobial Agents & Chemotherapy, 2017. 61(7): p. e00277-00217. PMID[28507107].
[PubMed]. HIV_06_2017.
6. HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-competent and Multi-drug-resistant HIV in Human Cells. Hilimire, T.A., J.M. Chamberlain, V. Anokhina, R.P. Bennett, O. Swart, J.R. Myers, J.M. Ashton, R.A. Stewart, A.L. Featherston, K. Gates, E.D. Helms, H.C. Smith, S. Dewhurst, and B.L. Miller. ACS Chemical Biology, 2017. 12(6): p. 1674-1682. PMID[28448121]. PMCID[PMC5477779].
[PubMed]. HIV_06_2017.
7. Towards Fluorinated Peptidic HIV-1 Fusion Inhibitors. Huhmann, S., E. Nyakatura, and B. Koksch. Journal of Peptide Science, 2016. 22: p. S90-S90. ISI[000398216100163].
[WOS]. HIV_06_2017.
8. The Effect of Ingenol-B on the Suppressive Capacity of Elite Suppressor HIV-specific CD8+ T Cells. Kwaa, A.K., K. Goldsborough, V.E. Walker-Sperling, L.F. Pianowski, L. Gama, and J.N. Blankson. Plos One, 2017. 12(5): p. e0174516. PMID[28467486]. PMCID[PMC5414940].
[PubMed]. HIV_06_2017.
9. RNA-protein Interactions Govern Antiviral Specificity and Encapsidation of Broad Spectrum anti-HIV Reverse Transcriptase Aptamers. Lange, M.J., P.D.M. Nguyen, M.K. Callaway, M.C. Johnson, and D.H. Burke. Nucleic Acids Research, 2017. 45(10): p. 6087-6097. PMID[28334941].
[PubMed]. HIV_06_2017.
10. SERINC Inhibits HIV-1 Env Induced Membrane Fusion and Slows Fusion Pore Enlargement. Markosyan, R.M., S.L. Liu, and F.S. Cohen. Biophysical Journal, 2017. 112(3): p. 79A-79A. ISI[000402328000406].
[WOS]. HIV_06_2017.
11. Diastereoselective Synthesis and Molecular Docking Studies of Novel Fused Tetrahydropyridine Derivatives as New Inhibitors of HIV Protease. Mohammadi, A.A., S. Taheri, A. Amouzegar, R. Ahdenov, M.R. Halvagar, and A.S. Sadr. Journal of Molecular Structure, 2017. 1139: p. 166-174. ISI[000400718500019].
[WOS]. HIV_06_2017.
12. Identification and Optimization of Thienopyridine Carboxamides as Inhibitors of HIV Regulatory Complexes. Nakamura, R.L., M.A. Burlingame, S. Yang, D.C. Crosby, D.J. Talbot, K. Chui, A.D. Frankel, and A.R. Renslo. Antimicrobial Agents and Chemotherapy, 2017. 61(7): p. e02366-02316. PMID[28416550].
[PubMed]. HIV_06_2017.
13. Amiloride as a New RNA-binding Scaffold with Activity against HIV-1 TAR. Patwardhan, N.N., L.R. Ganser, G.J. Kapral, C.S. Eubanks, J. Lee, B. Sathyamoorthy, H.M. Al-Hashimi, and A.E. Hargrove. MedChemComm, 2017. 8(5): p. 1022-1036. ISI[000402049300021].
[WOS]. HIV_06_2017.
14. HIV-1 gp41-targeting Fusion Inhibitory Peptides Enhance the gp120-targeting Protein-mediated Inactivation of HIV-1 Virions. Qi, Q., Q. Wang, W. Chen, L. Du, D.S. Dimitrov, L. Lu, and S. Jiang. Emerging Microbes & Infections, 2017. 6(6): p. e59. PMID[28634358].
[PubMed]. HIV_06_2017.
15. 5-Hydroxytyrosol Inhibits HIV-1 Replication in Primary Cells of the Lower and Upper Female Reproductive Tract. Saba, E., P. Panina-Bordignon, I. Pagani, M. Origoni, M. Candiani, C. Doglioni, G. Taccagni, S. Ghezzi, J. Alcami, E. Vicenzi, and G. Poli. Antiviral Research, 2017. 142: p. 16-20. PMID[28286236].
[PubMed]. HIV_06_2017.
16. SERINC5 Inhibits HIV Fusion through Inactivation of Env Glycoproteins and Interference with Productive Refolding of Env. Sood, C., M. Marin, A. Chande, A.L. Mattheyses, K. Salaita, M. Pizzato, and G. Melikian. Biophysical Journal, 2017. 112(3): p. 79A-79A. ISI[000402328000405].
[WOS]. HIV_06_2017.
17. Mid-size Drugs: Dimer & Trimer Mimics of HIV-gp41 Peptides as Fusion Inhibitors. Tamamura, H. Journal of Peptide Science, 2016. 22: p. S18-S20. ISI[000398216100027].
[WOS]. HIV_06_2017.
18. Data on Eleven Sesquiterpenoids from the Cultured Mycelia of Ganoderma capense. Tan, Z., J. Zhao, J. Liu, M. Zhang, R. Chen, K. Xie, and J. Dai. Data in Brief, 2017. 12: p. 361-363. PMID[28491940]. PMCID[PMC5413196].
[PubMed]. HIV_06_2017.
19. Synthesis, Biological Evaluation and Molecular Modeling of 2-Hydroxyisoquinoline-1,3-dione Analogues as Inhibitors of HIV Reverse Transcriptase Associated Ribonuclease H and Polymerase. Tang, J., S.K.V. Vernekar, Y.L. Chen, L. Miller, A.D. Huber, N. Myshakina, S.G. Sarafianos, M.A. Parniak, and Z. Wang. European Journal of Medicinal Chemistry, 2017. 133: p. 85-96. PMID[28384548].
[PubMed]. HIV_06_2017.
20. Evaluation of Biphenylalanine and Its Derivatives as Potential HIV-1 gp120 Attachment Inhibitors Based on Molecular Docking, CD4 Capture ELISA and Cytotoxicity Analysis. Teoh, T.C., H.A. Rothan, and M.R. Idid. Chiang Mai Journal of Science, 2017. 44(2): p. 487-493. ISI[000402157900020].
[WOS]. HIV_06_2017.
21. Expression of HERV-K108 Envelope Interferes with HIV-1 Production. Terry, S.N., L. Manganaro, A. Cuesta-Dominguez, D. Brinzevich, V. Simon, and L.C.F. Mulder. Virology, 2017. 509: p. 52-59. PMID[28605635].
[PubMed]. HIV_06_2017.
22. Double-winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Vernekar, S.K.V., J. Tang, B. Wu, A.D. Huber, M.C. Casey, N. Myshakina, D.J. Wilson, J. Kankanala, K.A. Kirby, M.A. Parniak, S.G. Sarafianos, and Z. Wang. Journal of Medicinal Chemistry, 2017. 60(12): p. 5045-5056. PMID[28525279].
[PubMed]. HIV_06_2017.
23. Synthesis and Evaluation of Pyridinium Polyoxometalates as anti-HIV-1 Agents. Wang, S., W. Sun, Q. Hu, H. Yan, and Y. Zeng. Bioorganic & Medicinal Chemistry Letters, 2017. 27(11): p. 2357-2359. PMID[28431877].
[PubMed]. HIV_06_2017.
24. A Novel Preventive Strategy against HIV-1 Infection: Combinatorial Use of Inhibitors Targeting the Nucleocapsid and Fusion Proteins. Yang, Y., J. Zhu, M. Hassink, L.M.M. Jenkins, Y. Wan, D.H. Appella, J. Xu, E. Appella, and X. Zhang. Emerging Microbes & Infections, 2017. 6(6): p. e40. PMID[28588284].
[PubMed]. HIV_06_2017.
25. Potent Inhibitor of Drug-resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa. Zhang, H.J., E. Rumschlag-Booms, Y.F. Guan, D.Y. Wang, K.L. Liu, W.F. Li, V.H. Nguyen, N.M. Cuong, D.D. Soejarto, H.H.S. Fong, and L. Rong. Journal of Natural Products, 2017. 80(6): p. 1798-1807. PMID[28613071].
[PubMed]. HIV_06_2017.
Patent Citations
26. Antiviral Oxime phosphoramide Compounds. Fu, W., Z. Guo, N. Qi, I.T. Raheem, P. Vachal, M. Wang, and J.D. Schreier. Patent. 2017. 2016-US66075 2017106069: 69pp.
[Patent]. HIV_06_2017.
27. Amido-substituted Pyridotriazine Derivatives Useful as HIV Integrase Inhibitors and Their Preparation. Graham, T.H., T. Yu, S.T. Waddell, J.A. McCauley, A. Stamford, W. Liu, J.A. Grobler, and L. Xu. Patent. 2017. 2016-US61456 2017087257: 77pp.
[Patent]. HIV_06_2017.
28. Spirocyclic Pyridotriazine Derivatives Useful as HIV Integrase Inhibitors and Their Preparation. Graham, T.H., T. Yu, S.T. Waddell, J.A. McCauley, A. Stamford, W. Liu, J.A. Grobler, and L. Xu. Patent. 2017. 2016-US61455 2017087256: 88pp.
[Patent]. HIV_06_2017.
29. Compositions and Methods for Reactivating Latent Human Immunodeficiency Virus Using an Akt Activator. Gramatica, A. and W.C. Greene. Patent. 2017. 2016-US64614 2017096161: 50pp.
[Patent]. HIV_06_2017.
30. Preparation of Tetrahydroisoquinoline Derivatives as Antivirals Agents for the Treatment of HIV Infection. Johns, B.A., E.J. Velthuisen, and J.G. Weatherhead. Patent. 2017. 2016-IB57270 2017093938: 225pp.
[Patent]. HIV_06_2017.
31. Preparation of Isoindoline Derivatives for the Treatment of Viral Infections. Johns, B.A., E.J. Velthuisen, and J.G. Weatherhead. Patent. 2017. 2016-IB57269 2017093937: 34pp.
[Patent]. HIV_06_2017.